Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration

Lancet Infect Dis. 2006 Aug;6(8):483-95. doi: 10.1016/S1473-3099(06)70549-7.

Abstract

Tuberculosis is the oldest of the world's current pandemics and causes 8.9 million new cases and 1.7 million deaths annually. The disease is among the most common causes of morbidity and mortality in people living with HIV. However, tuberculosis is more than just part of the global HIV problem; well-resourced tuberculosis programmes are an important part of the solution to scaling-up towards universal access to comprehensive HIV prevention, diagnosis, care, and support. This article reviews the impact of the interactions between tuberculosis and HIV in resource-limited settings; outlines the recommended programmatic and clinical responses to the dual epidemics, highlighting the role of tuberculosis/HIV collaboration in increasing access to prevention, diagnostic, and treatment services; and reviews progress in the global response to the epidemic of HIV-related tuberculosis.

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / epidemiology
  • AIDS-Related Opportunistic Infections / prevention & control
  • Anti-HIV Agents / therapeutic use*
  • Disease Outbreaks
  • Global Health*
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • Health Services Accessibility*
  • Humans
  • Prevalence
  • Treatment Outcome
  • Tuberculosis / complications
  • Tuberculosis / drug therapy
  • Tuberculosis / epidemiology
  • Tuberculosis / prevention & control*
  • Tuberculosis, Multidrug-Resistant / complications
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / prevention & control

Substances

  • Anti-HIV Agents